ESTILOS DE VIDA, SALUD VASCULAR Y ENVEJECIMIENTO ACTIVO (ESVE)
ESVE
Karolinska Institute
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska Institute (5)
2019
-
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
The Lancet, Vol. 394, Núm. 10193, pp. 121-130
-
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
The Lancet, Vol. 394, Núm. 10193, pp. 131-138
-
Neurological disorders in central Spain, second survey: Feasibility pilot observational study
Journal of Medical Internet Research, Vol. 21, Núm. 1
2017
-
Rivaroxaban with or without aspirin in stable cardiovascular disease
New England Journal of Medicine, Vol. 377, Núm. 14, pp. 1319-1330
2013
-
Leg fat might be more protective than arm fat in relation to lipid profile
European Journal of Nutrition, Vol. 52, Núm. 2, pp. 489-495